Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands.
about
Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cost-effectiveness analysis of ...... boembolism in the Netherlands.
@en
type
label
Cost-effectiveness analysis of ...... boembolism in the Netherlands.
@en
prefLabel
Cost-effectiveness analysis of ...... boembolism in the Netherlands.
@en
P2093
P2860
P1476
Cost-effectiveness analysis of ...... boembolism in the Netherlands.
@en
P2093
Eric B W Giesen
Harald E Heemstra
Maarten J Postma
Maarten J Treur
P2860
P304
P356
10.1080/13696998.2017.1331912
P407
P50
P577
2017-05-18T00:00:00Z